Providing an Update on IPF Biomarkers: Uncovering the Emerging Consensus on Which Biomarker Best Predicts Disease Progression to Help Maximize the Success of Your ILD Therapeutic in a Clinical Setting

Time: 9:00 am
day: Day Two


  • Reviewing findings from previous clinical trials
  • Emerging biological and digital biomarkers
  • Health equity in biomarker development